VanEck Biotech ETF Rating $160.64 -2.23 (-1.37%) Closing price 03:53 PM EasternExtended Trading$160.71 +0.07 (+0.04%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.66Holdings in BBH have an aggregate rating of Moderate Buy based on 492 analyst ratings issued in the past year covering 25 companies (99.8% of the portfolio).BBH Aggregate Price Target$160.64High Prediction$160.64Average Prediction$160.64Low Prediction$160.64Holdings in BBH have an aggregate price target of $160.64 and a range of $160.64 to $160.64 covering 25 companies (99.8% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.03%AMGNAmgen$306.86-2.4%4.1765 of 5 stars2.46$314.04 2.3%24Positive News13.68%GILDGilead Sciences$107.89+1.1%4.4849 of 5 stars2.72$104.52 -3.1%29Positive News12.62%VRTXVertex Pharmaceuticals$509.04-0.5%3.8617 of 5 stars2.65$506.70 -0.5%26Positive News5.98%REGNRegeneron Pharmaceuticals$634.14-4.1%4.8627 of 5 stars2.76$973.13 53.5%25Positive News5.07%ARGXargenx$605.52-0.4%3.4777 of 5 stars2.91$687.00 13.5%23Positive News4.21%IQVIQVIA$181.07-2.7%4.8388 of 5 stars2.86$249.05 37.5%21Positive News4.03%NTRANatera$154.58+0.5%2.9437 of 5 stars3.00$178.12 15.2%16Positive News3.74%ALNYAlnylam Pharmaceuticals$280.96-3.4%4.5739 of 5 stars2.76$312.30 11.2%25Analyst UpgradeNews Coverage3.11%ICLRICON Public$179.02-2.9%4.4202 of 5 stars2.80$272.50 52.2%153.02%BIIBBiogen$139.16-1.7%4.8475 of 5 stars2.43$213.33 53.3%30News CoveragePositive News2.57%ILMNIllumina$87.53-0.6%4.6466 of 5 stars2.48$140.90 61.0%21Positive News2.42%ONCBeigene$250.47-1.1%1.2589 of 5 stars3.00$310.00 23.8%32.23%INSMInsmed$78.54-1.1%3.8212 of 5 stars3.00$94.00 19.7%162.21%BNTXBioNTech$97.05-3.6%3.2808 of 5 stars2.89$143.73 48.1%182.11%MRNAModerna$33.85-0.9%4.1053 of 5 stars2.04$59.00 74.3%242.07%NBIXNeurocrine Biosciences$116.18+0.5%4.8916 of 5 stars2.83$165.24 42.2%23Positive News1.78%SRPTSarepta Therapeutics$73.61-3.6%4.5729 of 5 stars2.83$167.41 127.4%231.75%TECHBio-Techne$59.98-1.8%4.8938 of 5 stars2.56$81.25 35.5%91.64%CRLCharles River Laboratories International$161.57-3.2%4.4637 of 5 stars1.94$189.77 17.5%161.57%QGENQiagen$39.69-0.3%4.0428 of 5 stars2.30$47.71 20.2%101.54%INCYIncyte$62.08-1.1%4.8188 of 5 stars2.21$74.88 20.6%19Analyst Forecast1.43%BMRNBioMarin Pharmaceutical$71.53-0.6%4.9852 of 5 stars2.71$94.00 31.4%24Analyst Revision1.31%RGENRepligen$141.95-2.2%4.7513 of 5 stars2.57$178.64 25.8%141.10%EXASExact Sciences$45.67-3.0%4.4019 of 5 stars2.90$70.83 55.1%20Positive News0.59%CYTKCytokinetics$44.55-4.3%4.3591 of 5 stars2.94$82.00 84.1%18Positive News This page (NASDAQ:BBH) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBH Stock Free BBH Stock Alerts